These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37833411)

  • 1. Complement receptor type 1 and 2 (CR1 and CR2) gene polymorphisms and plasma protein levels are associated with the Dengue disease severity.
    Diep NT; Giang NT; Diu NTT; Nam NM; Khanh LV; Quang HV; Hang NT; Mao CV; Son HV; Hieu NL; Linh PT; Sklan EH; Toan NL; Tong HV
    Sci Rep; 2023 Oct; 13(1):17377. PubMed ID: 37833411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.
    Donius LR; Orlando CM; Weis JJ; Weis JH
    Immunobiology; 2014 Jan; 219(1):53-63. PubMed ID: 24012440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
    Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
    J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
    Quigg RJ; Holers VM
    J Immunol; 1995 Aug; 155(3):1481-8. PubMed ID: 7636211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
    J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD; Fearon DT
    Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mouse model expressing human forms for complement receptors CR1 and CR2.
    Jackson HM; Foley KE; O'Rourke R; Stearns TM; Fathalla D; Morgan BP; Howell GR
    BMC Genet; 2020 Sep; 21(1):101. PubMed ID: 32907542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
    J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
    Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
    Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
    Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
    Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of resting B cells is modulated by CR2 and CR1.
    Fingeroth JD; Heath ME; Ambrosino DM
    Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
    Neher MD; Rich MC; Keene CN; Weckbach S; Bolden AL; Losacco JT; Patane J; Flierl MA; Kulik L; Holers VM; Stahel PF
    J Neuroinflammation; 2014 May; 11():95. PubMed ID: 24885042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
    Leslie RG; Prodinger WM; Nielsen CH
    Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.
    Donius LR; Handy JM; Weis JJ; Weis JH
    J Immunol; 2013 Jul; 191(1):434-47. PubMed ID: 23733878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.
    Delibrias CC; Kazatchkine MD; Fischer E
    Scand J Immunol; 1993 Aug; 38(2):183-9. PubMed ID: 8346417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products.
    Martin BK; Weis JH
    Eur J Immunol; 1993 Nov; 23(11):3037-42. PubMed ID: 7693486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE.
    Boackle SA; Culhane KK; Brown JM; Haas M; Bao L; Quigg RJ; Holers VM
    Autoimmunity; 2004 Mar; 37(2):111-23. PubMed ID: 15293881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.